Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
Saved in:
| Title: | Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Laukkanen S; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Veloso A; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Yan C; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Oksa L; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Alpert EJ; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Do D; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Hyvärinen N; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., McCarthy K; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Adhikari A; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Yang Q; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Iyer S; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Garcia SP; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Pello A; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Ruokoranta T; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland., Moisio S; The Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland., Adhikari S; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Yoder JA; Department of Molecular Biomedical Sciences, Comparative Medicine Institute, and Center for Human Health and the Environment, North Carolina State University, Raleigh, NC., Gallagher K; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA., Whelton L; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Allen JR; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Jin AH; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA., Loontiens S; Cancer Research Institute Ghent and Center for Medical Genetics, Ghent, Belgium., Heinäniemi M; The Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland., Kelliher M; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA., Heckman CA; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Lohi O; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Tampere University Hospital, Tays Cancer Center, Tampere, Finland., Langenau DM; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA. |
| Source: | Blood [Blood] 2022 Oct 27; Vol. 140 (17), pp. 1891-1906. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35544598 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Laukkanen+S%22">Laukkanen S</searchLink>; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Veloso+A%22">Veloso A</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Yan+C%22">Yan C</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Oksa+L%22">Oksa L</searchLink>; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Alpert+EJ%22">Alpert EJ</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Do+D%22">Do D</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Hyvärinen+N%22">Hyvärinen N</searchLink>; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22McCarthy+K%22">McCarthy K</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Adhikari+A%22">Adhikari A</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Yang+Q%22">Yang Q</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Iyer+S%22">Iyer S</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Garcia+SP%22">Garcia SP</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Pello+A%22">Pello A</searchLink>; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Ruokoranta+T%22">Ruokoranta T</searchLink>; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Moisio+S%22">Moisio S</searchLink>; The Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.<br /><searchLink fieldCode="AU" term="%22Adhikari+S%22">Adhikari S</searchLink>; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Yoder+JA%22">Yoder JA</searchLink>; Department of Molecular Biomedical Sciences, Comparative Medicine Institute, and Center for Human Health and the Environment, North Carolina State University, Raleigh, NC.<br /><searchLink fieldCode="AU" term="%22Gallagher+K%22">Gallagher K</searchLink>; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA.<br /><searchLink fieldCode="AU" term="%22Whelton+L%22">Whelton L</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Allen+JR%22">Allen JR</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Jin+AH%22">Jin AH</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Loontiens+S%22">Loontiens S</searchLink>; Cancer Research Institute Ghent and Center for Medical Genetics, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Heinäniemi+M%22">Heinäniemi M</searchLink>; The Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.<br /><searchLink fieldCode="AU" term="%22Kelliher+M%22">Kelliher M</searchLink>; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA.<br /><searchLink fieldCode="AU" term="%22Heckman+CA%22">Heckman CA</searchLink>; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Lohi+O%22">Lohi O</searchLink>; Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Tampere University Hospital, Tays Cancer Center, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Langenau+DM%22">Langenau DM</searchLink>; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA.; Harvard Stem Cell Institute, Boston, MA.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2022 Oct 27; Vol. 140 (17), pp. 1891-1906. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35544598 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2021015106 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1891 Titles: – TitleFull: Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Laukkanen S – PersonEntity: Name: NameFull: Veloso A – PersonEntity: Name: NameFull: Yan C – PersonEntity: Name: NameFull: Oksa L – PersonEntity: Name: NameFull: Alpert EJ – PersonEntity: Name: NameFull: Do D – PersonEntity: Name: NameFull: Hyvärinen N – PersonEntity: Name: NameFull: McCarthy K – PersonEntity: Name: NameFull: Adhikari A – PersonEntity: Name: NameFull: Yang Q – PersonEntity: Name: NameFull: Iyer S – PersonEntity: Name: NameFull: Garcia SP – PersonEntity: Name: NameFull: Pello A – PersonEntity: Name: NameFull: Ruokoranta T – PersonEntity: Name: NameFull: Moisio S – PersonEntity: Name: NameFull: Adhikari S – PersonEntity: Name: NameFull: Yoder JA – PersonEntity: Name: NameFull: Gallagher K – PersonEntity: Name: NameFull: Whelton L – PersonEntity: Name: NameFull: Allen JR – PersonEntity: Name: NameFull: Jin AH – PersonEntity: Name: NameFull: Loontiens S – PersonEntity: Name: NameFull: Heinäniemi M – PersonEntity: Name: NameFull: Kelliher M – PersonEntity: Name: NameFull: Heckman CA – PersonEntity: Name: NameFull: Lohi O – PersonEntity: Name: NameFull: Langenau DM IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 10 Text: 2022 Oct 27 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 140 – Type: issue Value: 17 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |